Eton Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2024 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2024 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q4 2024 | 1 | -$0.02 | -$0.01 | -$0.02 |
| Q1 2025 | 1 | $0.06 | $0.07 | $0.07 |
| Q2 2025 | 1 | $0.07 | $0.07 | $0.07 |
| Q3 2025 | 1 | $0.13 | $0.15 | $0.14 |
| Q4 2025 | 1 | $0.17 | $0.19 | $0.18 |
Eton Pharmaceuticals, Inc. Earnings Date And Information
Eton Pharmaceuticals, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $0.02 earnings per share for the quarter, topping analysts' consensus estimates of $0.004 by $0.016. The company had revenue of 10.32 M for the quarter and had revenue of 31.64 M for the year. Eton Pharmaceuticals, Inc. has generated $0 earnings per share over the last year ($-0.0365 diluted earnings per share) and currently has a price-to-earnings ratio of -50.8. Eton Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based on prior year's report dates.
Eton Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | $0.00 | $0.02 | 0.02 | $9.70 M | $10.32 M |
| 08/08/2024 | Q2 2024 | -$0.07 | -$0.12 | -0.05 | $8.80 M | $9.07 M |
| 05/09/2024 | Q1 2024 | -$0.07 | -$0.03 | 0.04 | $7.97 M | |
| 03/22/2024 | Q4 2023 | -$0.09 | $7.31 M | |||
| 11/09/2023 | Q3 2023 | -$0.10 | -$0.02 | 0.08 | $6.26 M | $7.03 M |
| 08/10/2023 | Q2 2023 | $0.09 | $0.18 | 0.09 | $6.50 M | $12.00 M |
| 05/11/2023 | Q1 2023 | -$0.14 | -$0.11 | 0.03 | $5.30 M | |
| 03/16/2023 | Q4 2022 | $0.01 | $0.04 | 0.03 | $8.50 M | |
| 11/10/2022 | Q3 2022 | -$0.15 | -$0.13 | 0.02 | $3.05 M | $3.22 M |
| 08/11/2022 | Q2 2022 | -$0.02 | -$0.06 | -0.05 | $7.80 M | $7.36 M |
| 05/12/2022 | Q1 2022 | -$0.08 | -$0.22 | -0.14 | $2.18 M | |
| 03/16/2022 | Q4 2021 | $0.19 | $0.04 | -0.15 | $6.09 M | |
| 11/16/2021 | Q3 2021 | -$0.24 | $3.04 M | $775,000 | ||
| 08/16/2021 | Q2 2021 | -$0.14 | -$0.08 | 0.06 | $3.83 M | $3.07 M |
| 05/13/2021 | Q1 2021 | $0.19 | $0.21 | 0.02 | $11.90 M | |
| 03/16/2021 | Q4 2020 | -$0.26 | -$0.32 | -0.06 | $81,000 | |
| 11/12/2020 | Q3 2020 | -$0.26 | -$0.31 | -0.05 | $1.06 M | $-161,000 |
| 08/12/2020 | Q2 2020 | -$0.28 | -$0.23 | 0.05 | $294,333 | $20,000 |
| 05/14/2020 | Q1 2020 | -$0.24 | -$0.50 | -0.26 | $99,000 | |
| 03/05/2020 | Q4 2019 | -$0.29 | -$0.15 | 0.14 | $459,000 |
Eton Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Eton Pharmaceuticals, Inc.'s earnings date?
Eton Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates.
-
Did Eton Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Eton Pharmaceuticals, Inc. (:ETON) reported $0.02 earnings per share (EPS) to beat the analysts' consensus estimate of $0.004 by $0.016.
-
How can I listen to Eton Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Eton Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Eton Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Eton Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Eton Pharmaceuticals, Inc. generate each year?
Eton Pharmaceuticals, Inc. (:ETON) has a recorded annual revenue of $31.64 M.
-
How much profit does Eton Pharmaceuticals, Inc. generate each year?
Eton Pharmaceuticals, Inc. (:ETON) has a recorded net income of $31.64 M. Eton Pharmaceuticals, Inc. has generated $-0.0365 earnings per share over the last four quarters.
-
What is Eton Pharmaceuticals, Inc.'s price-to-earnings ratio?
Eton Pharmaceuticals, Inc. (:ETON) has a price-to-earnings ratio of -50.8 and price/earnings-to-growth ratio is -2.64.
